Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
---|
06/28/2007 | US20070148136 Methods of using ammonia oxidizing bacteria |
06/28/2007 | US20070148135 Combination bacteriolytic therapy for the treatment of tumors |
06/28/2007 | US20070148074 Nanoparticle based stabilization of ir fluorescent dyes |
06/27/2007 | EP1801112A1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
06/27/2007 | EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
06/27/2007 | EP1800664A1 Pharmaceutical formulations for parenteral administration comprising epothilone |
06/26/2007 | US7235691 Dissolving modafinil in a solvent selected from acetone, acetonitrile, benzyl alcohol, dimethyl formamide, methyl ethyl ketone, pyrrolidone and mixtures thereof, crystallizing, and separating the solvent; high purity; X-ray diffraction patterns; dosage forms |
06/26/2007 | US7235628 Analogues of GLP-1 |
06/26/2007 | US7235564 11'-substituted; potent inhibitors of cellular mitosis and proliferation |
06/26/2007 | US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
06/26/2007 | US7235248 Pharmaceutical compositions comprising cyclosporins |
06/21/2007 | WO2005037223A3 Methods and compositions for immunomodulation |
06/21/2007 | WO2004084833A8 Jucara and açai fruit-based dietary supplements |
06/21/2007 | WO2004078135A3 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF |
06/21/2007 | US20070142399 Dual function drugs and uses thereof |
06/21/2007 | US20070142348 Microbicidal, prophylactic and therapeutic effect of ctc-96 on papilloma viruses |
06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
06/21/2007 | US20070141632 Function and regulation of angiopoietin-3/angiopoietin-4 |
06/21/2007 | US20070141140 Semi-solid formulations for immediate release intended for the oral administration of drugs |
06/21/2007 | US20070141136 intravenously administering to mammal a therapeutically effective amount of a liposomal suspension of small unilamellar vesicles (SUVs), wherein SUVs predominantly comprise phospholipids selected from phosphatidycholine, phosphatidylglycerol and phosphatidylserine |
06/21/2007 | US20070141080 Treating severe acute respiratory syndrome |
06/21/2007 | US20070141068 Methods for the treatment of carcinoma |
06/21/2007 | US20070140988 Therapeutic agent for periodontal disease |
06/20/2007 | EP1796699A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
06/20/2007 | EP1758540A4 Purification of insulin-like material by reverse phase chromatography |
06/20/2007 | EP1663186B1 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
06/20/2007 | EP1594517B1 Compositions for the treatment of gastrointestinal disorders |
06/20/2007 | EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins |
06/20/2007 | CN1984926A Fsh糖基化突变体 Fsh glycosylation mutants |
06/20/2007 | CN1984921A Modulation of survivin expression |
06/20/2007 | CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor |
06/20/2007 | CN1982355A Anti-microbial and oxidative co-polymer |
06/20/2007 | CN1982308A Substituted pyrazoles |
06/20/2007 | CN1981747A Rapidly disintegrating methylcellulose tablets |
06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
06/19/2007 | US7232841 N-{4-[2-(1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-ethyl]-cyclohexyl}-2-[2-({4-[2-(1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-ethyl]-cyclohexylcarbamoyl}-methyl)-phenyl]-acetamide; treating COPD |
06/19/2007 | US7232824 Used for treating disorders with enhanced activity of transforming growth factor beta TGF- beta, kidney disorders associated with unregulated TGF- beta activity and excessive fibrosis including glomerulonephritis (GN), mesangial proliferative GN, immune GN, and crescentic GN |
06/19/2007 | US7232823 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders |
06/19/2007 | US7232805 Cobalamin conjugates for anti-tumor therapy |
06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
06/14/2007 | WO2007065967A1 A vaccine suitable for use against the next influenza a pandemia |
06/14/2007 | WO2005051308A3 Methods of treating diseases and disorders by targeting multiple kinases |
06/14/2007 | WO2005044189A3 Dialysates and methods and systems related thereto |
06/14/2007 | WO2005016236A3 Antibodies that immunospecifically bind to trail receptors |
06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
06/14/2007 | US20070135478 3-(2-Benzyl-2-hydroxy-3-phenyl-propylidene)-8,8-dimethyl-8-azonia-bicyclo[3.2.1]octane iodide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
06/14/2007 | US20070135470 Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof |
06/14/2007 | US20070135400 Estradiol derivatives |
06/14/2007 | US20070135382 Use of peroxisome proliferator-activated receptor gamma (ppary) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions |
06/14/2007 | US20070135364 Compositions and methods for the modulation of the expression of b7 protein |
06/14/2007 | US20070135353 Crystalline n-formyl hydroxylamine compounds |
06/14/2007 | US20070134757 Method for cleaving proteins |
06/14/2007 | US20070134719 Method of controlling pharmacokinetics of immunomodulatory compounds |
06/14/2007 | US20070134653 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases |
06/14/2007 | US20070134269 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
06/14/2007 | US20070134268 Vaccines |
06/14/2007 | US20070134214 Inactivated host cell delivery of polynucleotides encoding immunogens |
06/13/2007 | EP1558931B1 Analysis of pharmaceutical solubility and stability |
06/13/2007 | EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof |
06/13/2007 | EP1381352B1 Transdermal patch for administering fentanyl |
06/13/2007 | EP1105145B1 Reducing serum homocysteine concentration by the use of allium and vitamins |
06/13/2007 | CN1980916A Chemokine receptor binding heterocyclic compounds |
06/13/2007 | CN1980692A Polypeptides for inducing a protective immune response against staphylococcus aureus |
06/12/2007 | US7230133 For prophylaxis of of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis |
06/12/2007 | US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
06/12/2007 | US7230013 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth |
06/12/2007 | US7230003 Aromatic prodrugs of propofol, compositions and uses thereof |
06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
06/12/2007 | US7229648 Homeopathic formulations useful for treating pain and/or inflammation |
06/12/2007 | US7229413 Echogenic coatings with overcoat |
06/12/2007 | CA2238410C Novel indole-2,3-dione-3-oxime derivatives |
06/07/2007 | WO2007063186A1 Face mask |
06/07/2007 | WO2007011232A3 Lipid lowering agents for increasing bmd |
06/07/2007 | WO2005052132A3 Mbms as modifiers of branching morphogenesis and methods of use |
06/07/2007 | WO2005046596A3 Stem cell culture medium and method of using said medium and the cells |
06/07/2007 | WO2005020918A3 Ultrasonic concentration of drug delivery capsules |
06/07/2007 | WO2005016234A3 Compositions, methods, apparatuses, and systems for singlet oxygen delivery |
06/07/2007 | WO2005011619A3 Lung-expressed polypeptides |
06/07/2007 | WO2004112702A3 Low dose pharmaceutical powders for inhalation |
06/07/2007 | WO2004110369A3 Cell surface protein associated with human chronic lymphocytic leukemia |
06/07/2007 | US20070129740 Methods And Devices For Creating Electrical Block At Specific Targeted Sites In Cardiac Tissue |
06/07/2007 | US20070129439 Compositions containing substituted quinolines and substituted diphenyl sulfones and methods of use |
06/07/2007 | US20070129396 Muscarinic acetylcholine receptor antagonists |
06/07/2007 | US20070129392 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
06/07/2007 | US20070129311 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents |
06/07/2007 | US20070129292 Treatment of aspergillus infections with alpha thymosin peptides |
06/07/2007 | US20070128642 Clearing misfolded proteins from blood via incubation with proteon nucleation center (PNC) which comprise metallic nanoparticles consisting of copper, zinc and/or iron; diagnosing metabolic disorders |
06/07/2007 | US20070128630 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced |
06/07/2007 | US20070128241 Methods, compositions, apparatuses containing tetrameric oxygen |
06/07/2007 | US20070128216 Derived from recombinant attenuated intracellular pathogenic bacteria, specifically, attenuated Mycobacteria that over-express and secrete major extracellular proteins; useful in inducing immune responses in hosts |
06/07/2007 | US20070128181 Administering within 12 hours after cardiac surgery to patient a blood clotting inhibitor such as a combination of dipyridamole and aspirin, wherein cardiac surgery does not include vein graft coronary artery bypass graft surgery; decreases complications without significant adverse effects; efficiency |
06/07/2007 | US20070128176 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
06/06/2007 | EP1792628A1 Vaccines |
06/06/2007 | EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases |
06/06/2007 | EP1684768A4 Methods of treating eczema |
06/06/2007 | EP1682606B1 Anion-binding polymers and uses thereof |
06/06/2007 | EP1620459A4 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |